Cherison Cuffy, DPM

PROFESSIONAL ACADEMIC EXPERIENCE (INCLUDES HISTORY OF RANK AT BARRY) Assistant Professor Barry University SPM Miami, FL 2014- Present Clinical Investigator Brand Research Center Barry University SPM, Miami, FL 2014 – Present OTHER PROFESSIONAL EXPERIENCE Assistant Director Residency Program Northwest Medical Center Margate, FL 2016 - Present Clinical Supervisor Residency Program Jackson North Medical Center Miami, FL 2017- Present Faculty Physician Wound Care Center, University Hospital Tamarac, FL 2010 Faculty Physician Wound Care Center, Broward Health Coral Springs, FL 2010 Physician Private Practice, Tamarac, FL 2010 PROFESSIONAL LICENSURE [AND CERTIFICATIONS] (IF APPLICABLE) Florida, 2006 Doctor Of Podiatric Medicine, March 31, 2020 Board Certified, Diplomat, American Board of Foot & Ankle Surgery 2017 - Present Board Certified, Diplomat, American Board of Podiatric Medicine 2016- Present Board Certified, Diplomat, American Board of Wound Management, CWS, 2010- Present SCHOLARLY ACTIVITIES PUBLICATIONS/WRITING Snyder RJ. Ead JK, Cuffy C.(2018). Chapter 5: Wound Assessment. Textbook of Chronic Wound Care, Shah, Sheffield and Fife(ed.), Snyder, Section Editor: Best Publishing Company: Florida pg 103-110 PEER REVIEWED Snyder RJ, Kimawi AA, Cuffy CA, Cala MA. When Traditional Offloading is not an Option, Could an External Fixator be a Solution?: A Case Report. Wounds 2017;29(2):46–50 Snyder RJ, Cuffy, CA, Glick B, Ead, J. Dehydrated Human Amnion/Chorion Membrane as Adjunctive Therapy in the Mulidisciplinary Treatment of Pyoderma Gangrenosum: A Case Report. Ostomy Wound Management September 2015;61(9):40-49 NOT PEER-REVIEWED Snyder RJ, Cuffy C, Ead J. Fischborn, K Chronic Wound Biochemistry. Advanced Wound Dressings Today June 2019; Spring Supplement p4-11 Snyder RJ, Ead JK, Cuffy, C. et al. Is PASH Syndrome a Biofilm Disease?: A Case Series and Review of the Literature. Wounds 2018: 30(8): 216-223 Cuffy, CA, Patel SP, Saysoukha V, Snyder, RJ, Merrill T. Comprehensive Care and Management of Foot Infection in an Imunocompromised Patient: A Case Report. Podiatry Institute Update 2017 Chapter 17 Jafary H, Ramos R, Cuffy, C, Merrill T. Multiple Foot Fractures Treated With Multiple Minirail External Fixation: A Case Report. Podiatry Institute Update 2017 Chapter 39 Snyder RJ, Cuffy C, Ead J. Charcot Foot: An Overview of the Pathophysiology and Conservative Treatments. Current Dialogues in Wound Management March 2017;3(1) Snyder RJ, Cuffy C, Cala M, Jafary H. Surgical Treatment of Charcot Foot. Current Dialogues in Wound Management March 2017;3(1) Snyder, RJ, Cuffy CA, Ead JK. Charcot Neuropathic Osteo-Arthropathy: Pathophysiogy – Conservative Treatment. Current Dialogues in Wound Management 2016 Snyder, RJ, Cuffy, CA. Idiopathic Dystrophic Calcinosis with Chronic Changes Representative of Squamous Cell Cancer. Podiatry Management, February 2011 Cuffy, CA, Lieberman, J. Case Study: Medial Column Fusion. Present Courseware 2010 PRESENTATIONS/PERFORMANCES/EXHIBITS PEER-REVIEWED FPMA SAM Conference - Poster: "Reconstruction of the Achilles Tendon After a Lawn Mower Accident Using an Autograft Gastrocnemius Aponeurosis Free Flap: A Case Report AGNES Seminar, Barry University, Miami, FL 2018 AGNES Seminar, Barry University, Miami, FL 2019 FPMA Summer Conference, Bonita Springs, FL 2019 C3 Limb Salvage and Advanced Wound Care Summit Case Presentation Competition 2019 NOT PEER-REVIEWED Total Contact Casting Made Easy: The Gold Standard in Off-Loading 2014 "Diabetic Foot; saving lives by saving limbs" AWARDS OR GRANTS RESEARCH STUDIES Novartis Pharmaceuticals- A Longitudinal Study of Human Skin Wounds (BIOMARKER) 2018 B. Braun Medical, Inc.- A Prospective Study of Quality of Life in Patients with Chronic Leg Wounds Treated with Prontosan Wound Irrigation Solution and Prontosan Wound Gel 2018 Tides Medical Venous and Diabetic Foot Ulcers- The Efficacy and Safety of Artacent for Treatment of Resistant Lower Extremity Venous and Diabetic Ulcers: A Prospective Randomized Study 2018 Integra Life Sciences Corporation T-AEPDFU-01- Prospective, Multi-Center, Randomized, Parallel-Group Study Comparing AmnioExcel Plus, Placental Allograft Membrane to Apligraf , Bi-Layered Skin Substitute and Standard of Care Procedures in the Management of Diabetic Foot Ulcers 2017 - Present Integra Life Sciences Corporation T-PMXDFU-01- Prospective, Multi-Center, Randomized Controlled Trial Evaluating the use of Primatrix Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers 2017- Present Factor Therapeutics VF00102- A Prospective, Multi-center, Double-Blind, Randomized, Placebo Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients with Chronic Venous Leg Ulcers 2017- Present Nu-Tech-NT-DFU-AFF-02- A Multicenter, Randomized Controlled Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers: Crossover Group from Standard of Care 2017 – Present Nu-Tech-NT-DFU-AFF-01- A Multicenter, Randomized Controlled Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers 2017 – Present SerenaGroup Cellutome-VLU-013– A Multicenter, Randomized, Open-Label, Controlled Clinical Trial Evaluating Suction Blister Grafting Utilizing a Novel Harvesting Device (Cellutome©) and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers 2016 Tactile Medical 6010 – A Phase 2 Randomized Trial Comparing a Dual Action Pneumatic Compression System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers 2016 RedDress RD-003 – A Multicenter, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers 2015- Present Osiris 303 – A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers 2015-Present DermaScience Stride 5: Open-Label Phase 3 ClinicalTrial to Evaluate the Safety of 0.03% DSC127 Gel in Chronic Use for Treating Diabetic Foot Ulcers. 2014-2015 Dipexium 305: A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults with Mild Infections of Diabetic Foot Ulcers. 2014- Present Xoma, LLC, Protocol X052172 "A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum" 2015 - 2016 DermaScience AmnioExcel: A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers 2015-2016 Macrocure , Protocol Number MC-105 "A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, 13Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in 02Treating Chronic Venous Leg" April 2014 – 2015 SanuWave, Protocol SAN12-DERM02 "A Double-Blind, Multi-center, Randomized, Sham-Controlled, Parallel Group Comparison of the dermaPACE® (pulse Acoustic Cellular Expression) Device in Conjuction with Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers" October 2013 - 2016 Xoma , LLC, Protocol X052171 "A 2 Year Open-Label, Safety Extension Study of Gevokizumab in the Treatment of Patients with Pyoderma Gangrenosum" 2013- 2016 Xoma, LLC, Protocol X052170 "An Open-Label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum" April 2013 - 2016 DermaSciences, Protocol Number DSC 127-2012-01 "A Randomized, Double-Blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus" January 2013 - 2015 Macrocure , Protocol Number MC-102 CureXcell™ "A Phase III, Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Sham-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell™ as an adjunct to Good Wound Care Measures in Treating Lower Extremity Chronic Ulcers in Adults with Diabetes Mellitus" October 2013 - 2015 CoDa Therapeutic, Protocol Number NEX-ULC-011 "A Randomized, Prospective, Double-blind, Vehicle-controlled, Dose-ranging, Multi-center Study to Assess the Safety and Clinical Effect of Nexagon® (NEXAGON) in the Treatment of Subjects with a Diabetic Foot Ulcer" - July 2012 -2013 Healthpoint, Ltd., Protocol Number 802-247-09-031"A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12cm2 to ≤36cm2" September 2012 – March 2014 Healthpoint, Ltd., Protocol Number 802-247-030 "A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcers" September 2012 – March 2014 INSTRUCTIONAL ACTIVITIES TEACHING RESPONSIBILITIES COURSE NUMBER COURSE TITLE # SEMESTERS TAUGHT SPM 632 Podiatric Medicine I 6 SPM 731 Podiatric Medicine IV SPM 825 Practice Management 4 STUDENT MENTORING Developing and Writing Numerous Articles with Students for Publication in Podiatric Journals Journal Club Advisor Overseeing Journal Article Presentations Dermatology Club Advisor Presentation: How to Perform Wound Debridement 2017 Lecture at Barry Seminar 2016 SNPMA Student National Podiatric Medical Association Advisor UNIVERSITY GOVERNANCE Barry University Member, Faculty Senate Welfare Committee, Barry University 2016-2017 Member, Communique Committee 2017, 2018, 2019 MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS AAWC Association for the Advancement of Wound Care ABWM American Board of Wound Management APMA American Podiatric Medical Association FPMA Florida Podiatric Medical Association ABFAS American Board of Foot and Ankle Surgery ABPM American Board of Podiatric Medicine ACFAS American College of Foot and Ankle Surgeons MEMBERSHIPS IN COMMUNITY ORGANIZATIONS Hospital Affiliations University Hospital, Tamarac, Florida Northwest Medical Center, Margate, Florida Coral Springs Medical Center, Coral Springs, Florida Jackson North Medical Center, North Miami, Florida Member, Credentials and Qualifications Committee, University Hospital 2013 – Present Member, Pharmacy and Therapeutics, Northwest Medical Center 2013- Present Alpha Phi Alpha Fraternity, Inc. PROFESSIONAL SERVICE SERVICE TO PROFESSIONAL SOCIETIES Editorial Review Board Member, Wound Management & Prevention, HMP Communications; 2019 Ad Hoc Reviewer, Wound Management & Prevention, HMP Communications; 2019 SERVICE TO THE COMMUNITY Hands On Broward 2019 Vision Worship Center Youth Career Day 2019 Diabetes Awareness and Foot Care Wellness 2018 Yucatan Crippled Children’s Project 2018 No Perfect People Inc 2018- Present NPPI Serve the City Back to School Leader 2019 Thanksgiving Meal Setup Leader; 2017, 2018 Broward Health Coral Springs Medical Center Foot Screenings 2016, 2017, 2018, 2019 Trilogy Home Health Care Nurse Education: Wound Management of Skin Grafts 2017 Barry Homeless Foot Screening : First Methodist Church 2014 COMMUNITY PRESENTATIONS Mount Hermon AME Church- Miami, Fl The Effect of Diabetes on the Lower Extremity 2018 Women Designed for Excellence Conference: Church on the Way- Miami, Fl The Effect of Diabetes on the Lower Extremity 2017 Health & Wellness Presentation 2015 HONORS AND AWARDS 2016 "Clinical Faculty of the Year" Barry University School of Podiatric Medicine Class of 2016 2014 "Wound Care Physician Scholarship" winner Symposium on Advanced Wound Care (SAWC) 2014